Edition:
United States

Tina Bellon

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Jul 20 2018

Bayer to phase out Essure birth control device in U.S.

NEW YORK Life sciences company Bayer AG said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device that made the business no longer sustainable.

Jul 20 2018

Bayer to phase out Essure birth control device in U.S.

NEW YORK, July 20 Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device which made the business no longer sustainable.

Jul 19 2018

Women who sued J&J declare victory after $4.69 billion talc verdict

NEW YORK A woman who claimed her cancer was caused by using Johnson & Johnson's baby powder for decades said she believes justice was served after a jury found the company should pay her and 21 other women $4.69 billion in damages.

Jul 13 2018

J&J vows to overturn $4.7 billion talc verdict but experts see hurdles

NEW YORK Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company's products gave them ovarian cancer by arguing the plaintiffs' science was flawed and the case should not have been heard in Missouri. | Video

Jul 12 2018

Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.

Jul 12 2018

Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case

A Missouri jury on Thursday ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer.

Jul 12 2018

Lawsuit over sunflower seed recall can proceed -federal judge

A federal judge in Aberdeen, South Dakota on Wednesday denied natural and organic food processor SunOpta Inc's motion for summary judgment in a lawsuit by a customer who bought contaminated sunflower kernels that were subject to a 2016 recall.

Jul 11 2018

Multi-plaintiff St. Louis talc case against J&J goes to jury

Missouri state court jurors on Wednesday heard closing arguments in the case of 22 women who allege their use of Johnson & Johnson's talc products caused them to develop ovarian cancer in the largest trial the company has faced over such allegations to date.

Jul 10 2018

Bayer, J&J put Xarelto MDL appeals push on hold pending SCOTUS review

A federal judge overseeing the multidistrict litigation over Bayer AG and Johnson & Johnson's blood thinner Xarelto on Monday granted the companies' request to withdraw motions for summary judgment and interlocutory appeal pending a decision by the U.S. Supreme Court in a separate drug case.

Jul 10 2018

Colgate-Palmolive settles talc cancer case ahead of trial

Colgate-Palmolive on Monday settled after eight days of jury selection a lawsuit brought by a California man who alleged his use of talcum powder made by the company's predecessor exposed him to asbestos and caused his mesothelioma.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary